Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07694492 · ClinicalTrials.gov registry record · NA

Feasibility of a Medical-Legal Partnership Model to Connect Coal Miners QuitAid

A NA study, sponsored by University of Virginia.

Not yet
Registry status
NA
Development phase
120
Enrollment target

NCT07694492 is a NA study that has not yet begun recruiting, run by University of Virginia. The registered enrollment target is 120 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07694492, a NA study, has not yet begun recruiting, sponsored by University of Virginia.

NOT YET RECRUITING
Registry status
NA
Development phase
120 participants
Enrollment target

Study Summary

Coal miners in Central Appalachia have among the highest rates of tobacco and nicotine product (TNP) use of any occupational group and face elevated rates of lung cancer and coal workers' pneumoconiosis ("black lung"). This study tests a novel medical-legal partnership (MLP) that "flips" the traditional referral direction: lawyers representing coal miners in black-lung workers' compensation cases identify clients who use TNPs and, through an ask-advise-connect process, connect them to community pharmacists who deliver QuitAid, a pharmacist-delivered medication therapy management (MTM) program, together with nicotine replacement therapy (NRT). The study has two aims: (1) an implementation-science evaluation of the ask-advise-connect process in black-lung law offices, and (2) a randomized feasibility pilot in which coal miners who use TNPs are randomized to receive QuitAid or not, with all participants receiving 24 weeks of NRT. As a feasibility pilot, the study is designed to estimate recruitment, randomization, retention, fidelity, and dose parameters to inform a future NCI R01, and is not powered to detect differences between conditions.

Interventions

  • DRUG Nicotine Replacement Therapy (NRT)
  • BEHAVIORAL QuitAid (pharmacist-delivered MTM)

Trial Details

FieldValue
Enrollment Target 120 participants
Start Date 2026-09-01
Est. Completion 2027-12-31
Phase NA

Sponsor

University of Virginia

449 total trials

What the Registry Record Tells You About NCT07694492

The ClinicalTrials.gov registry entry for NCT07694492 describes a study currently listed as not yet recruiting, categorized as NA. The registered enrollment target is 120 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Virginia, which has 449 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Nicotine Replacement Therapy (NRT) is the first listed.

NCT07694492 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT07694492 about?

NCT07694492 is a clinical study titled "Feasibility of a Medical-Legal Partnership Model to Connect Coal Miners QuitAid". Coal miners in Central Appalachia have among the highest rates of tobacco and nicotine product (TNP) use of any occupational group and face elevated rates of lung cancer and coal workers' pneumoconiosis ("black lung"). This study tests a novel medical-legal partnership (MLP) that "flips" the traditi...

What is the current status of trial NCT07694492?

This trial is currently not yet recruiting. It is a NA study. The enrollment target is 120 participants. The study started on 2026-09-01. Estimated completion is 2027-12-31.

What interventions are being tested in trial NCT07694492?

The interventions under investigation include: Nicotine Replacement Therapy (NRT) (DRUG), QuitAid (pharmacist-delivered MTM) (BEHAVIORAL).

Who is sponsoring clinical trial NCT07694492?

This trial is sponsored by University of Virginia, which has 449 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.